Fortress Biotech, Inc. Checkpoint Therapeutics, Inc. (CKPT) insider trading activity

Fortress Biotech, Inc. is of Checkpoint Therapeutics, Inc.. Currently has a direct ownership of 3.74 Million shares of CKPT, which is worth approximately $12.6 Million. The most recent transaction as insider was on Sep 27, 2024, when has been sold 146,341 shares (Common Stock, par value $0.0001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.74M

0% 3M change

96.36% 12M change

Total Value Held $12.6 Million

Fortress Biotech, Inc. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 27 2024	BUY Grant, award, or other acquisition	-	146,341 Added 3.77%	3,735,534 Common Stock, par valu...
Mar 20 2024	BUY Grant, award, or other acquisition	-	193,905 Added 8.47%	2,096,278 Common Stock, par valu...
Dec 29 2023	BUY Grant, award, or other acquisition	-	158,134 Added 7.67%	1,902,373 Common Stock, par valu...
Sep 25 2023	BUY Grant, award, or other acquisition	-	80,906 Added 4.43%	1,744,239 Common Stock, par valu...
Jun 30 2023	BUY Grant, award, or other acquisition	-	81,406 Added 4.67%	1,663,333 Common Stock, par valu...
Apr 04 2023	BUY Grant, award, or other acquisition	-	42,500 Added 2.62%	1,581,927 Common Stock, par valu...
Mar 31 2023	BUY Grant, award, or other acquisition	-	35,714 Added 2.27%	1,539,427 Common Stock, par valu...
Jan 05 2023	BUY Grant, award, or other acquisition	-	368,907 Added 19.7%	1,503,713 Common Stock, par valu...

Also insider at

ATXI

AVENUE THERAPEUTICS, INC. Healthcare

> 10% Shareholder

MBIO

MUSTANG BIO, INC. Healthcare

> 10% Shareholder

DERM

Journey Medical Corp Healthcare

> 10% Shareholder

FBI